Literature DB >> 19101034

DNA repair gene XPD and XRCC1 polymorphisms and the risk of childhood acute lymphoblastic leukemia.

Bahadir Batar1, Mehmet Güven, Safa Bariş, Tiraje Celkan, Inci Yildiz.   

Abstract

Polymorphisms have been identified in several DNA repair genes. These polymorphisms may effect DNA repair capacity and modulate cancer susceptibility. In this study, we aimed to determine the four polymorphisms in two DNA repair genes, xeroderma pigmentosum complementation group D (XPD) and X-ray repair cross-complementing group 1 (XRCC1), in a sample of Turkish patients with childhood acute lymphoblastic leukemia (ALL), and evaluate their association with childhood ALL development. We used polymerase chain reaction (PCR) and restriction fragment length polymorphism (RFLP), to analyze XPD Asp312Asn, XPD Lys751Gln, XRCC1 Arg194Trp, and XRCC1 Arg399Gln polymorphisms in 70 patients with childhood ALL and in 75 disease-free controls, who were of a similar age. No significant differences were observed among the study groups with regard to the XPD codon 312, XPD codon 751, XRCC1 codon 194, and XRCC1 codon 399 polymorphisms. However, the combined XRCC1 Arg194Trp/Trp194Trp variant genotypes were associated with increased risk for ALL in females (OR=5.47; 95% CI=1.49-20.10; p=0.008). This finding indicates that females carrying XRCC1 194Trp allele are at increased risk of developing childhood ALL. These results suggest that the risk of childhood ALL may be associated with DNA repair mechanisms, and understanding these mechanisms will help identify individuals at increased risk of developing childhood ALL, and also should be lead to improved treatment of ALL.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19101034     DOI: 10.1016/j.leukres.2008.11.005

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  26 in total

Review 1.  Candidate gene association studies and risk of childhood acute lymphoblastic leukemia: a systematic review and meta-analysis.

Authors:  Jayaram Vijayakrishnan; Richard S Houlston
Journal:  Haematologica       Date:  2010-05-29       Impact factor: 9.941

2.  DNA repair gene XRCC1 polymorphisms and susceptibility to childhood acute lymphoblastic leukemia: a meta-analysis.

Authors:  Juan Du; Cong Lu; Guohui Cui; Yan Chen; Jing He
Journal:  Chin J Cancer Res       Date:  2013-08       Impact factor: 5.087

3.  XRCC1 Arg399Gln variation and leukemia susceptibility: evidence from 2,647 cases and 5,518 controls.

Authors:  Yi Huang; Denghai Xie; Nana Tang; Jishi Wang; Xiaoqing Zeng; Peng Zhao; Ling He
Journal:  Tumour Biol       Date:  2013-08-30

4.  Association between the XRCC1 Arg194Trp polymorphism and risk of cancer: evidence from 201 case-control studies.

Authors:  Yan-Zhong Feng; Yi-Ling Liu; Xiao-Feng He; Wu Wei; Xu-Liang Shen; Dao-Lin Xie
Journal:  Tumour Biol       Date:  2014-07-27

5.  Hodgkin lymphoma risk: role of genetic polymorphisms and gene-gene interactions in DNA repair pathways.

Authors:  Claudia M Monroy; Andrea C Cortes; Mirtha Lopez; Elizabeth Rourke; Carol J Etzel; Anas Younes; Sara S Strom; Randa El-Zein
Journal:  Mol Carcinog       Date:  2011-03-03       Impact factor: 4.784

6.  Insulin-like growth factor 1 gene polymorphism in women with breast cancer.

Authors:  Danylo Rafhael Costa-Silva; Maria da Conceição Barros-Oliveira; Rafael Soares Borges; Larysse Maira Campos-Verdes; João Paulo da Silva-Sampaio; Carla Solange Escorcio-Dourado; Luana Mota Martins; Airlane Pereira Alencar; Edmund Chada Baracat; Vladimir Costa Silva; Benedito Borges da Silva
Journal:  Med Oncol       Date:  2017-03-17       Impact factor: 3.064

7.  Study on the association between the Arg194Trp polymorphism in the XRCC1 gene and the risk of hematological malignancies.

Authors:  Lizhi Tang; Tianyuan Xiong; Qingyi Jia; Qing He; Xiang Tong; Yuanling Peng; Jiani Shen; Jiqiao Yang; Yonggang Zhang
Journal:  Tumour Biol       Date:  2014-01-12

8.  The association of polymorphisms in DNA base excision repair genes XRCC1, OGG1 and MUTYH with the risk of childhood acute lymphoblastic leukemia.

Authors:  M Stanczyk; T Sliwinski; M Cuchra; M Zubowska; A Bielecka-Kowalska; M Kowalski; J Szemraj; W Mlynarski; I Majsterek
Journal:  Mol Biol Rep       Date:  2010-04-04       Impact factor: 2.316

9.  Concurrent effects of ABCB1 C3435T, ABCG2 C421A, and XRCC1 Arg194Trp genetic polymorphisms with risk of cancer, clinical output, and response to treatment with imatinib mesylate in patients with chronic myeloid leukemia.

Authors:  Hana Salimizand; Sabrieh Amini; Mohammad Abdi; Bayazid Ghaderi; Namam-Ali Azadi
Journal:  Tumour Biol       Date:  2015-08-07

10.  Polymorphisms in XPC provide prognostic information in acute myeloid leukemia.

Authors:  Peipei Xu; Baoan Chen; Jifeng Feng; Lu Cheng; Guohua Xia; Yufeng Li; Jun Qian; Jiahua Ding; Zuhong Lu
Journal:  Int J Hematol       Date:  2012-09-12       Impact factor: 2.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.